Loading company…
Pluslife develops molecular diagnostic technologies and point-of-care testing products.
Founded in 2017 and based in Guangzhou, China, Pluslife develops molecular diagnostic products and point-of-care tests using gene technologies. Its MiniDock and Dock Pro 8 systems use RHAM technology to test for infectious diseases including tuberculosis and sexually transmitted infections. In November 2025, it raised Series A+ funding from FC Innovation Venture Fund, Puhua Capital and Guangzhou Guoju Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in